Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...
Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...
Bracco Imaging is expanding into the cell therapy space to explore new applications of its long-established microbubble technology.
Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...
Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...
Bracco’s cell selection and activation microbubble technology is designed to support both positive- and negative-selection strategies.
The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...
With the power of robotics and the personalized medicine expertise of one of Japan's top drugmakers, Astellas Pharma and Yaskawa Electric Corporation are setting off on a joint venture to help ...
The first half of 2025 has been a notable one for Cellares. The cell therapy manufacturer operates its first commercial-scale Integrated Development and Manufacturing Organization Smart Factory in ...
- Joint venture will aim to develop a cell therapy manufacturing platform through robotics and will offer access to startups and academic institutions - In the pharmaceutical industry, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results